Completed
Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
NCT00739986
- Conditions
- Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
- Locations
-
- Institute of Healthcare Assessment San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Atlanta Gastroenterology Associates Atlanta, Georgia, United States
- Advanced Gastroenterology Associates Suwanee, Georgia, United States